sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
atggaggatgagttattctggga | 59 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]}],"locations":["2->2"],"infos":["OTHER"]}] |
atggaggatgagttattctggga | 59 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atggaggatgagttattctggga | 59 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atttgctgtaataccaaaactaa | 4337 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atttgctgtaataccaaaactaa | 4337 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atttgctgtaataccaaaactaa | 4337 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
atttgctgtaataccaaaactaa | 4337 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctacagaagtgcacttccttgag | 5443 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctacagaagtgcacttccttgag | 5443 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctacagaagtgcacttccttgag | 5443 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctacagaagtgcacttccttgag | 5443 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gcagaacgagctctggtgctt | 6651 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gcagaacgagctctggtgctt | 6651 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gcagaacgagctctggtgctt | 5597 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gcagaacgagctctggtgctt | 5597 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gcagaacgagctctggtgctt | 5597 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gcagaacgagctctggtgctt | 5597 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gcagaacgagctctggtgctt | 6651 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gcagaacgagctctggtgctt | 6651 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcagctggctgtaatgcgtgcgg | 2923 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tcagctggctgtaatgcgtgcgg | 2923 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tcagctggctgtaatgcgtgcgg | 2653 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcagctggctgtaatgcgtgcgg | 2653 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcagctggctgtaatgcgtgcgg | 2653 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcagctggctgtaatgcgtgcgg | 2653 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcagctggctgtaatgcgtgcgg | 2923 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tcagctggctgtaatgcgtgcgg | 2923 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 1385 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tgaatgcacactaacgtaata | 1385 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tgaatgcacactaacgtaata | 2194 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 2194 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 847 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 847 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 847 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 847 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 2194 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tgaatgcacactaacgtaata | 2194 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
tgaatgcacactaacgtaata | 1385 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaatgcacactaacgtaata | 1385 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaaggactgagtgacctttgtt | 4537 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaaggactgagtgacctttgtt | 4537 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaaggactgagtgacctttgtt | 4537 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tgaaggactgagtgacctttgtt | 4537 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaccatatctggcacatccgtct | 6320 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaccatatctggcacatccgtct | 6320 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaccatatctggcacatccgtct | 6320 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
aaccatatctggcacatccgtct | 6320 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cttttgctttaatgctaaattcc | 1958 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cttttgctttaatgctaaattcc | 1958 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cttttgctttaatgctaaattcc | 1958 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
cttttgctttaatgctaaattcc | 1958 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagatttttgtatcacattat | 2991 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagatttttgtatcacattat | 2991 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagatttttgtatcacattat | 2991 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gagagatttttgtatcacattat | 2991 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tataagatgcttctctgtaaaat | 1178 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tataagatgcttctctgtaaaat | 1178 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tataagatgcttctctgtaaaat | 1716 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tataagatgcttctctgtaaaat | 1716 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tataagatgcttctctgtaaaat | 1178 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tataagatgcttctctgtaaaat | 1178 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
tataagatgcttctctgtaaaat | 1716 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
tataagatgcttctctgtaaaat | 1716 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
ttgacaatgccttctgtccattt | 4232 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgacaatgccttctgtccattt | 4232 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgacaatgccttctgtccattt | 4232 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
ttgacaatgccttctgtccattt | 4232 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"Vinyl-phosphonate 2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"inf... |
ttgacaatgccttctgtccattt | 3694 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgacaatgccttctgtccattt | 3694 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgacaatgccttctgtccattt | 3694 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgacaatgccttctgtccattt | 3694 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agagaccaagatgaagtttccca | 8332 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agagaccaagatgaagtttccca | 8332 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agagaccaagatgaagtttccca | 8332 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
agagaccaagatgaagtttccca | 8332 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gaaaatgatcgcctcttggtatg | 4548 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gaaaatgatcgcctcttggtatg | 4548 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gaaaatgatcgcctcttggtatg | 4548 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gaaaatgatcgcctcttggtatg | 4548 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 439 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gtcctgaaactgcaactagat | 439 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gtcctgaaactgcaactagat | 169 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 169 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 439 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 439 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 6780 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gtcctgaaactgcaactagat | 6780 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methylguanosine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["gm"]},{"modificationType":"Chemical","modification":["Phosphorothioate","2'-O-methyl"]}]}],"locations":["1->1"],"infos... |
gtcctgaaactgcaactagat | 169 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 169 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 6780 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
gtcctgaaactgcaactagat | 6780 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctttggtaaacgagatttaacat | 2038 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctttggtaaacgagatttaacat | 2038 | IL309897A | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctttggtaaacgagatttaacat | 2038 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ctttggtaaacgagatttaacat | 2038 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgggtttctttagtttatga | 3391 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgggtttctttagtttatga | 3391 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
ttgggtttctttagtttatga | 4738 | IL309897A0 | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
ttgggtttctttagtttatga | 4738 | IL309897A0 | הרכבי IRNA גן מטרה הקשור להפרעה מטבולית ושיטות לשימוש בהם | 20,240,201 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | [{"norInfos":[{"sourceData":"OTHER","norInfo":[{"modificationType":"Other"}]},{"sourceData":"2'-O-methyluridine-3'-phosphorothioate","norInfo":[{"modificationType":"Non natural base","modification":["um"]},{"modificationType":"Chemical","modification":["Phosphorothioate"]}]}],"locations":["1->1"],"infos":["OTHER","2'-O... |
ttgggtttctttagtttatga | 3929 | IL309897A | Metabolic disorder-associated target gene irna compositions and methods of use thereof | 20,240,301 | 101 | [
"CN",
"IN",
"US",
"WO",
"JP",
"NZ",
"CL",
"EP",
"RU",
"HK",
"IL",
"SG",
"CA",
"TW",
"CO",
"ZA",
"SA",
"AU",
"MX",
"AR",
"BR",
"KR"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.